Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis: results from phase IV ASTRUM study.
Uta KiltzXenofon BaraliakosJan Brandt-JürgensUlf WagnerSebastian LiebChristian SiederChristian MannJüergen BraunPublished in: Therapeutic advances in musculoskeletal disease (2024)
ClinicalTrials.gov; NCT02763046, EudraCT 2015-004575-74.